PR Newswire Asia's news > Health Care/Hospital

 |   Title only   |   Print    Next page > 
     
NECC Selects MedMinder to Transform Their Medication Management for Individuals with Autism They Serve
NORWOOD, Mass. , July 4, 2025 /PRNewswire/ -- The New England Center for Children (NECC), a globally recognized leader in autism education and research, has contracted with MedMinder, to enhance the ...
2025-07-04T    Education   Health Care/Hospital   Medical/Pharmaceuticals   Telecommunications 
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results
JILIN, China , July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer ...
2025-07-03T    Banking/Financial Service   Biotechnology   Health Care/Hospital 
NUS researchers develop novel material for water quality monitoring device
Introducing ReSURF sensor – an ultrafast, stretchable, self-healing and recyclable sensing device that enables on-site, real-time surveillance of water quality within milliseconds ...
2025-07-03T    Computer/Electronics   Education   Environmental Products & Services   Health Care/Hospital 
Fangzhou Tops China's App Store Chart for Healthcare Apps
GUANGZHOU, China , July 3, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, earned the top spot in the ...
2025-07-03T    Health Care/Hospital   Medical/Pharmaceuticals   Mobile Entertainment 
MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform
BOSTON , July 3, 2025 /PRNewswire/ -- MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii , PhD, MBA, ...
2025-07-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Esaote presents at ECVS 2025 the new generation of veterinary MRI, Vet -MR Grande ELITE
GENOA, Italy and ANTWERP, Belgium , July 3, 2025 /PRNewswire/ --  Esaote , a leading company in the field of medical diagnostic imaging, presents the new Vet -MR Grande ELITE, the next generation ...
2025-07-03T    Computer Software   Computer/Electronics   Health Care/Hospital   Medical Equipment 
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy
HONG KONG , July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical ...
2025-07-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Novotech Earns Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs and small- mid-size ...
2025-07-03T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
ZEGFROVY is the only  approved  targeted oral treatment  for  NSCLC  with EGFR   exon20 ins A pproval follows the U.S. FDA's Priority Review and is supported ...
2025-07-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
Highlights: ...
2025-07-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.